*Sponsored Message on Behalf of Nutriband Inc. Please see disclosures below.
| Analyst Initiates Coverage on "NTRB" | Hey Folks,
Nutriband (NTRB) has received a boost of confidence from Noble Capital analyst Robert LeBoyer, who initiated coverage with an Outperform rating and a $13 price target.
LeBoyer's analysis is fueled by the company's promising Phase 1 clinical trial, which is expected to demonstrate robust abuse-deterrent properties in its drug delivery system.
This success could enable Nutriband to file an "NDA" by the second half of 2025, with potential FDA approval anticipated by late 2026.
If successful, these milestones would position Nutriband as a leader in the abuse-deterrent pharmaceutical market, enhancing its reputation and opening doors to lucrative partnerships and revenue streams.
Approval of its innovative technology could solidify the company's competitive edge while addressing a critical public health need. |  | Here are a some other reasons why NTRB is worth paying attention to this morning... 1. Strong IP Portfolio: The company holds proprietary patents for its technology, creating a protective moat around its products.
2. Growing Market Potential: The transdermal drug delivery market is expected to grow significantly, providing Nutriband with a lucrative opportunity to capture market share.
3. Unique Focus on Safety: The company's flagship product, the AVERSA™ abuse-deterrent transdermal patch, targets a critical need in the opioid crisis by preventing misuse of prescription medications. 4. FDA and Regulatory Momentum: Nutriband has made meaningful progress in securing FDA approvals, enhancing its credibility and positioning for growth.
5. Innovative Product Line: Nutriband focuses on transdermal drug delivery systems, a cutting-edge technology offering safer and more efficient alternatives to traditional oral or injectable methods.
Anyways...
Have a great rest of your day!
-Damian | Want our text alerts? Text "ALERT" to 1-(888)-670-9763 to sign up!
(standard carrier data/text rates apply) | *Sponsored Message on Behalf of Nutriband Inc. Please see disclosures below.
| InsiderOwl is a financial newsletter powered by ZipTrader that offers insight into the latest insider trades. This includes CEOs, CFOs, Big Money Institutions, Politicians, and More.
*SPONSORED CONTENT* ZipTrader LLC is a publishing company, we are not financial advisors. This is not financial advice. Investments involve risk and are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Past performance is not indicative of future performance. ZipTrader has been compensated fifty thousand USD by ACH Bank Transfer by Lifewater Media to distribute media via email, SMS, YouTube, X/Twitter, Discord, and Facebook for Nutriband Inc. (NTRB) from January 21, 2025 through January 22, 2025. ZipTrader may receive additional campaigns in the future by Lifewater Media to distribute media for Nutriband Inc. (NTRB). ZipTrader has been compensated fifteen thousand USD by ACH Bank Transfer by Lifewater Media to distribute media via email and SMS for Nutriband Inc. (NTRB) from July 26, 2023 through July 28, 2023. ZipTrader has been compensated twenty-five thousand USD by ACH Bank Transfer by Lifewater Media to distribute additional media for Nutriband Inc. (NTRB) on July 26, 2023. As a result of this advertisement and other marketing efforts, ZipTrader may receive advertising revenue from new advertisers and collect email addresses from readers that it may be able to monetize. As of the date of this advertisement, the owners of ZipTrader do not hold a position in Nutriband Inc. (NTRB). This advertisement and other marketing efforts may increase investor and market awareness, which may result in an increased number of shareholders owning and trading the securities of Nutriband Inc. (NTRB), increased trading volume, and possibly an increased share price of Nutriband Inc. (NTRB), which may or may not be temporary and decrease once the marketing arrangement has ended.
BY READING THIS EMAIL & ALL ZIPTRADER CONTENT YOU AGREE: This is not financial advice. You must do your own due diligence on all information. ZIPTRADER LLC is a publishing company and we provide general information, opinions, & news coverage to viewers. However – we do not provide personalized financial advice, are not financial advisors, and our opinions are not suitable for all investors. You should not treat any opinion as expressed as a specific inducement to make a particular investment or follow a particular strategy, but just as an opinion. Use at your own risk. Past Performance is not indicative of future results, and any results presented are not typical, and should not be understood as typical. Actual results vary given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. TRADING IS RISKY: Most traders in all markets lose all of their money (and more if they use margin). Most small businesses fail. Do NOT partake in trading, investing, entrepreneurship or any other risky endeavor covered here if you are not prepared with the reality that most fail. We reserve the right to have affiliate relationships with advertisers/sponsors.
| Want To Stop Receiving Emails from InsiderOwl? |
ZipTrader LLC 5101 SANTA MONICA BLVD STE 8 #62, 90029, LOS ANGELES, CA | | | | |
No comments:
Post a Comment